Multiple Sclerosis (MS) is an eurodegenerativea utoimmune disorder caused by chronic inflammation and demyelination within the central nervouss ystem (CNS). Clinical studies in MS patients haved emonstrated efficacyw ith Bc ell targeted therapies such as anti-CD20. However, the exact role that Bcells play in the disease process is unclear. Activation Induced cytidine deaminase (AID) is an essential enzyme for the processes of antibody affinity maturation and isotype switching. To evaluate the impact of affinity maturation and isotype switching, we havei nterrogated the effect of AID-deficiency in an animal model of MS. Here, we show that the severity of experimental autoimmune encephalomyelitis (EAE) induced by the extracellular domain of human myelin oligodendrocyte glycoprotein (MOG1-125) is significantly reduced in Aicda deficient mice, which, unlike wild-type mice, lack serum IgG to myelin associated antigens. MOG specific Tc ell responses are comparable between wild-type and Aicda knockout mice suggesting an active role for antigen experienced Bcells. Thus affinity maturation and/or class switching are critical processes in the pathogenesis of EAE.
Introduction
MS is ac hronic demyelinating diseasei nw hicht he myelin of the CNS is the target of an autoimmune process [1] . Bc ells may play an important role in the pathogenesis of several humana utoimmune diseases including MS [reviewed in [2] ]. Bc ellsa re efficient antigen presenting cells (APCs) that can activate and provide Tc ell help to mount effective immune responses [3] . Bc ells can also producec ytokines to modulatethe inflammatoryresponse [4, 5] . Additionally,a utoantibodiesc an result in immune-mediated tissued estruction in experimental models [6] [7] [8] [9] [10] [11] [12] [13] . The oligoclonal bands identified from cerebrospinal fluidofMSpatientsare composed of immunoglobulins and recents tudies have suggestedt hat their presence may be ab iomarker for prognosisa nd/or subtypes of MS [14, 15] .
Supportingt his notion,Bcells found in the CNS of MS patientshavebeen shown to be clonally related, exhibit ap lasmablast phenotype andh aveu ndergone affinitym aturation, implicating antigen drivenBcell responses in MS [16] . IgG specific form yelin oligodendrocyteg lycoprotein (MOG)h aveb een demonstrated in MS patients [ 17, 18] . In an attempt to block these various effector functions, therapies aimed at modulating Bc ells and immune responses are in various stages of preclinical and clinical research [reviewed in [2] ]. Rituximab, am onoclonal antibody that selectively depletesC D20 expressing Bl ymphocytes,i sa pproved for rheumatoid arthritis (RA) and can reduce MS symptoms [19] .
In Bc ells, activation induced cytidine deaminase (AID) is essential for isotypes witching and affinity maturation of immunoglobulins [20] . Through somatich ypermutation( SHM), AIDi ntroduces single point mutations at high frequencyi nto the variable regions of the rearranged Ig heavy and light chains to generate high affinitya ntibodies [ 21] . Throughc lass switch recombination( CSR),t he Cm heavychain constant regionisexchanged forCa, Cg or Ce to produceIgA,IgG or IgE. Each classofAbhas a differente ffector function increasing thev ersatilityo f theA bs made by aBcell [21] .I ncreased expression of AIDh as been observed in inflammatoryd iseases including RA [22] allergic rhinitis [23] , Sjogren's syndrome [24] ,aswellasseveral Bcelllymphomas [25] .
TheroleofAID in thepathogenesisofautoimmune diseases hasbeendocumentedinexperimentalmodels. Inactivation of the Aicda gene in theM RL/lpr mouse modelofsystemiclupus significantly enhances survival [26, 27] . BXD2 mice,w hich area lsoa utoimmune prone, over-express AID, producep athogenica utoantibodies anddevelop severe arthritis andglomerulonephritis [ 28] a ll of whichc an be suppressed by transgenic expression of adominantnegativeAID [29] .
In this study,weaimed to specifically test the role of AID in the pathogenesis of recombinanth uman myelin oligodendrocyte glycoprotein( rhMOG) EAE [30] . Our results demonstrate that in the absence of AID, rhMOG-EAEi sp rofoundlya ttenuated suggesting that AID-dependentevents such as affinity maturation andisotypeswitching are critical processes involved in the EAE pathogenesis.A ccordingly, we show that MOGs pecific,h igha ffinity IgGa re abundanti nW Tm icew ith EAEa nd that serum IgG1 from these mice bind to brain tissue, whereas such antibodies are belowt he limito fd etection in Aicda deficient mice.
Materials and Methods

Animals
All animals usedi nt his study were houseda nd maintaineda tG enentech in accordancew ith American Association of LaboratoryA nimalC are guidelines. Alle xperimental studies were conducted under protocols(#12-1009 andsubletters) approved by the Institutional Animal Care and Use Committee of GenentechLab Animal Research in an AAALACiaccredited facilityi na ccordance with the Guide for theC area nd Useo fL aboratoryA nimals and applicable laws andr egulations.Bcell deficient (uMTK O) animals were purchasedf rom Jackson Laboratories( Bar Harbor, ME; colony #002288) along with controlWTanimals (colony #000664).
Generation of Aicda deficient mice
Thec onstruct fort argeting theC 57BL/6 Aicda locusi nE Sc ellsw as made using ac ombination of recombineering as well as standard molecular cloning techniques [31, 32] . Briefly,a8755 bp fragment (assemblyN CBI37/mm9, chr6:122,508,416-122,517,170) from am ouse BAC( RP23-470E2) was first retrievedi ntop lasmid pBlight-TK [ 31] . Seconda940 bp loxP-em7-kanamycin-loxP cassette was inserted upstream of exon 3b etween position chr6:122,510,801 and1 22,510,802.C orrectly targeted plasmid was transformed intoa rabinoseinduced SW106 cells [33, 34] to removek anamycin and leaveb ehind as ingle loxP site. Finally,a n frt-PGK-em7-Neo-BGHpA-frt-loxPc assettew as insertedd ownstream of exon 3b etween position chr6:122,511,674a nd 122,511,675, resulting in the Aicda targeting targeting vector. The final vector was confirmed by DNA sequencing.
The Aicda vector was linearized with NotI,C57BL/6 ES cells were targeted using standard methods (G418 positive andg ancyclovir negative selection),a nd positivec lonesw erei dentified usingP CR and Ta qMan w analysis. Correctly targeted ES cellsw ere transfected with aC re plasmidt or emoveN eo and create the Aicda KO allele. Aicda KO ES cells were then injected intob lastocysts using standard techniques, and germline transmission was obtained after crossing resulting chimaeras with C57BL/6 females.
Production of human MOG
Recombinant humanM OG was expressed and purified as previously described [ 35, 36] . Briefly,t he protein was expressed in inclusion bodies in Escherichia coli andprocessed underdenaturing conditions. The resulting material was purified andr efolded oncolumn usingN i-NTA-superflowr esin (Qiagen, Carlsbad, CA). Endotoxin was removed from the protein by incorporating a0 .1% Triton X-114 wash step prior to applying the glutathione redox buffers for refolding. The elutedp rotein was then dialyzedi nto 100 mM sodiump hosphate bufferp H8.0. Purity of the obtained preparation was verified by SDS-PAGE and the protein'sm olecular weight was confirmed by mass spectrometry.
EAE induction and clinicals coring
EAE was induced in 8-12-week-old female animals using recombinant human myelin oligodendrocyte glycoprotein (MOG) [ 35] a nd complete freunds adjuvant as previously described. Briefly, animals were injected subcutaneously on the back with a 
Histopathology
Braina nd spines were fixed in 10%n eutral buffered formalin.T issues were decalcified, trimmeda nd processed to 4 m ms ections stained with H þ E. Microscopice xamination wasperformed on 4c oronal sections of brain from each animal. Microscopic examinationo fs pine,i ncluding spinal cord at three levels (cervical, thoracic andlumbar) wasperformed on 2t o4transverses ectionsf rome achl evel fore ach animal.Lesions were scored accordingtoseverity on a scaleo f0(nol esions)t o3(severe).A verage lesion severity across alls ectionse xaminedw as compared across groupsand graphed usingAabel software v3.0.6.
Detection of brain tissue binding IgG in EAE derived sera by immunofluorescence
Ab rain sample collected from aS CID mouse (to avoid interference with endogenous immunoglobulin) wasf rozen in OCT( Tissue-Te k, Cat#4583, To rrance, CA) [37] . Sections were cut on acryotome and brieflyfixed in cold acetone.Sections were probed with sera collected at terminal sacrifice of mice induced with MOG to produce EAE. Mice represented Aicda.wt, Aicda.ko, uMT.wt and uMT.ko genotypes. Normal mouse serum at 1:20 was usedasa control. Sera were diluted 1:20 in PBS and incubated for 60 minutesa tr oom temperature.A fter washing with PBS,binding of IgG1 or IgM on brain tissue was detected using IgG1 and IgM specific secondary antibodies (Invitrogen, A21121 andA21042; 5ug/ml) conjugated to Alexa Fluor 488. Slides were imaged in aregion rich in myelinized white matter (brain stem at the cerebellar peduncle) using identical acquisition conditions. Images were examined for presence or absence of white-matter associatedfl uorescent signal without image modification.
Flow cytometry
Single cell suspensionsw ere prepared from draining lymph nodes (DLNs). Cells were stainedwith FITCconjugateda nti-CD44, PE-conjugateda nti-CD4, PerCp conjugated anti-CD8 and APC-conjugated anti-CD62L (BD Biosciences, San Jose, CA). Cell acquisition was performed on aFACScalibur (Becton Dickinson, Mountain View, CA) andd ataw as analyzed with Flowjo software (Ashland, OR).Isotype switchinga nalysisw as performeda sd escribed previously [38] .
In vitro cytokineassay
Te ndaysafter immunization,draininglymph node cells were isolated and culturedi n9 6-well flat-bottom plates at ac oncentration of 5 £ 10 5 cells/well in complete RPMI 1640 medium that contained1 0% heat-inactivated FCS, 1mMglutamine,1%penicillin-streptavidin, 1mMn onessentiala mino acids, and 5 £ 10
M2 -MEw ithv arious concentrations of recombinanth uman MOGp rotein (0,2 ,1 0a nd 50 ug/ml) or MOG 35 -55 peptide(0, 1, 5, and25ug/ml). Supernatants were collected4days afterc ulture for cytokinedetection by luminex(BioRad,Hercules, CA).
Detection of antibodies by ELISA
Serum sampleswere collected before and 28 days after immunization. Fordetection of anti-rMOG and anti-MOG35 -55p eptide autoantibodies, ELISA plates (Dynex Te chnologies, Chantilly,VA) were coated with rMOG (5 ì g/ml) or MOG35-55 peptide( 100 ug/ml) in PBS. Platesw erew ashedw ith PBS/0.05% Tween-20 andb locked with PBS/0.1% BSA. Serum samples were diluted at various concentrations and bound antibodiesw ere detected with AP-conjugated goat anti-mouse IgG andA P-conjugated goat antimouseI gM (SouthernB iotechnology Associates, Birmingham, AL)u sing 1-step PNPPs ubstrate (ThermoS cientific, Rockford, IL). The OD was measured at 405 nm by aSpectraMax 250 Microplate Reader (MolecularD evices,M enlo Park,C A). Experimental valuesw ere normalized to mixed day-28 sera of WT immunized mice for IgG antibodies and to mixed day 28 sera of Aicda KO immunizedmicefor IgM antibodies (arbitrarily defined as 100 U).
Anti-rhMOG-specific IgM assay
Form easurement of anti-rhMOG-specific IgM in mouse serum, 96-well microtiter ELISA plates were coatedo vernight at 4 8 Cw ith variousr hMOG concentrationsi nacarbonate buffer. Plates were washed, blocked with 200 m LE LISA assay diluent with BSA for 1-2h oursa tr oom temperature and washed. Normalized 0.1 mg/ml of total IgM from dilutedm ouse serum were added and incubated for 2hoursatroom temperature. The plates were washed three times andincubated with HRP-conjugated goat anti-mouse IgM-specific antibody for 30 min.
Role of AID in EAE
After washing three times, bound enzyme was detected with the sames teps as described below.F or measurement of total mouse IgM in serum, 96-well microtiter ELISA plates( Greiner, Germany) were coated overnighta t4 8 Cw ith 2 m g/ml Goat F(ab') 2 anti-mouseI g( SouthernBiotech)i nacarbonate buffer (pH 9.6). Plates were washed,b locked with 200 m LE LISA assay diluent with BSA for 1-2 hours at room temperature and washed. Diluted mouse serum samples or mouse IgM standards( BD BioSciences) were added and incubated for 2h ours at room temperature. To tal mouse IgM levels were quantitatedu sing HRP-conjugated Goat antimouse IgM-specific antibody (Invitrogen)f or 30 min. After washing three times, bound enzyme was detected by additiono f1 00 m L/well TMB substrate( BioFX Laboratories) for 5m inutes. The reactionsw ere stopped by adding1 00 m L/well of stop reagent (BioFXL aboratories) and detection of color at A 650 nm .
Surface plasmon resonance
Surface plasmonr esonance (SPR) was runo na Biacore 3000 (GE healthcare, Piscataway, NJ) at 258 C using recombinant MOG (described previously) amine-coupled to aB iacore CM5 sensor chip at 2,500 response units (RU) and ar eferencefl ow cell with humanI gG amine-coupled at 5,000R Us.
Injection flow rates were 5u l/min and sensorsw ere regenerated using 10 mM glycine pH 2.0 for3 0 secondsa taflow rate of 30 ul/min.S erum samples were usedd iluted 1:100 in HBS-P buffer (0.01 M Hepes, pH 7.4, 0.15 MN aCl, 0.005% Surfactant P20).A nti-mouseI gM (SouthernB iotech, cat# 1140-01),a nti-mouse IgG2a (Southern Biotech, cat# 1080 -01), and anti-mouse IgG1 (Southern Biotech, cat# 1070 -01) were used at 12.5 ug/ml dilutedi nH BS-P buffer. Fort he blocking study, recombinantMOG (2 uM) was incubated with 1:100 dilutedserum (Day 28, WT) for 1hrbefore injection over the sensor.
Results
Generation andcharacterizationofA icda-deficientm ice
The targetingstrategy usedtogenerate Aicda-deficient miceinC57BL/6background is depicted in Figure 1A . The deletion of exon-3 removes the majority of the catalytic domain of the Aicda gene and renderst he transcript outo ff rame. To assess the effecto nc lass switch recombination (CSR), splenocytes were stimulated with acombination of LPSand IL-4 for 4days, followed by FACS analysis for isotype usage.T his regimen promotes class switching from m to g 1. Wildtype (WT) splenic Bc ells were 25% IgG1 Aicda -deficient mice show decreased susceptibility to rhMOG-induced EAE Full or partial length recombinant antigens produced in E. coli presenta no pportunity to involve Bc ells in the EAE diseasem odel. These antigens havet hree dimensional structures andh aveb een shown to be bound by antibodies in their native conformation [39] [40] [41] . Strikingly,u MT-deficienta nimalsa re resistant to disease inductionw ithr ecombinant MOG protein (1 -125) but susceptible to MOG peptide3 5-55i nduced EAE [42, 43] . To determine whether or not AID plays ar ole in this resistance to rhMOG induced EAE, we immunized ac ohorto f animals containing wild-type and uMT-deficient mice (JacksonL abs) and Aicda wild-type and Aicdadeficient mice (bredatG enentech).
In these experiments, the incidence of disease was significantly reduced in animals deficient for eitheruMT (25% of the animals become sick) or AID (10%) as comparedt ow ild-type controls (100%; Figure 2 , Ta ble 1). Detailedhistopathology analysis of EAE CNS lesionsr evealed that both Aicda-deficient and uMT-deficientanimals are nearly devoid of CNS lesionsc ompared to the two WT cohortc ontrols ( Figure 2C-G) . EAE lesionssuch as myelinopathy and gliosis were present in the CNS in WT mice, whereas none of the Aicda KO histology sections revealed such severity. To gether these data suggest that AID is a critical component of the development of EAE. Figure 4B lower panels) . These studiessuggestthat the activation of CD4 þ Tcells is not affectedi n Aicda KO mice. To further test the function of Tc ells, dLN cells were re-stimulated with various doses of rhMOG or MOG 35 -55 peptide ex vivo.A sshown in Figure 3C , dLN cellsfrom both WT and Aicda KO mice produce substantial amounts of IL-17 in ad ose-dependentm anner to either rhMOG (left panel) or MOG 35 -55 peptide( right panel) stimulation. In total, these data suggest that the resistancet od isease induction observed in Aicda-deficient animals is not due to changes in Tcell activation or effectorfunction. 
High affinityI gG anti-MOGa uto-antibodies areonly abundanti nW Tanimals
AIDi se ssential forb otha ffinity maturation and isotypes witching. We measured the level of MOG-specific IgG or IgM auto-antibodies in WT and Aicda-deficient mice. We found that WT mice produced asubstantial amountofIgG against rhMOG ( Figure 4A ) and MOGp35 -55( Figure 4C ) 28 days after immunization. As expected, the levels of IgG against rhMOG andM OGp35 -55i n Aicda-deficient mice were below the limit of detection as these mice are unable to undergo class switch recombination [20] . In contrast, WT mice produced only a small amount of IgM against rhMOG ( Figure 4B ) or MOGp35 -55( Figure 4D ), whereas Aicda-deficient mice interestingly produced more IgM antibodies against rhMOG and MOGp35-55.
We then determined how well WT or IgM antiMOGa ntibodiesb ind to rhMOGa tl imiting concentrationstogain further insights into the affinity anda bundance of thesea ntibodies. Our results confirmed the ELISA study that WT mice produced only as mall amounto fI gM Abs against rhMOG whereas Aicda KO havesubstantially higher amount of anti-MOG antibodies ( Figure 4E ).Itispossible that a large fraction of rhMOG-specific antibodies from WT mice mighth ave class-switched to IgGi sotype, whereas this process is defective in Aicda-deficient miceresultinginexpansion of MOG specific germline encoded antibodies which might also have higher affinity. Although the total IgM Abs in mouse serum has been normalized, we cannot rule out that the startinga nti-MOG specific antibodies are the same across different groups. Our data suggests that IgM anti-MOG antibodiesinWTmice do not appear to be am ajor source of pathogenic antibodies since similar abs are even more represented in the Aicda KO group.
To better documentthe specificity,binding properties and the isotypeo ft he anti-MOG autoantibodies, surface plasmon resonance (SPR) analysis was used. SPR usesacontinuousflow technology to monitor the progresso fb iomolecular interactions in real time. An rhMOG specific binding response was detected in WT immunizeda nimals andt his signal could be inhibited with soluble rhMOG protein ( Figure 5A ). The majority of this binding was mediated by IgG1 class of anti-MOG antibodies( Figure 5B ). Thus IgG1 anti-MOG high affinity auto-antibodies are highly abundantinWTmice thatmight be the major source of pathogenic antibodies.
Myelin-specific IgG1and not IgM autoantibodies strongly bind to myelin tissue in CNS
To better understand the in vivo properties of the IgG1 or IgM autoantibodies observed, we asked whether or nott hese antibodiesc ouldr ecognize and bind CNS tissues [12, 37] . We performed indirect immunofluorescence assays using SCID brain tissue (to avoid the interference with endogenousi mmunoglobulin). Intriguingly,s erad erived from EAE affected Aicda wt or uMT wt mice produced strong signali nt he white matter when probed with antiIgG1, indicating the presence of isotype switched autoantibodies targeting white matter myelin in these mice( Figure 6 ). By contrast, white matter signal was virtuallya bsenti n Aicda .koo ru MT.kom ice, reflecting the absence of IgG, includingm yelinspecific autoantibodies, in these animals.
Normal mouse serum( i.e., derived from healthy, not EAEi nduced mice) yieldedw eak background signal, clearly different from the signal achieved with EAE derived serum. When examined for binding of IgM, brain sections probed with sera from MOG induced mice had similar signal distribution andlowlevel intensity regardless of genotype and comparable to normal mouse serum, indicating that IgM do not contribute to the pathogenesis of EAE in this model. This data suggests that the high affinityI gG1 antimyelin antibodies play an important role in EAE and the absence of these high affinity IgG1 anti-MOG antibodies in Aicda deficient mice may contribute to the resistance in diseasei nduction as supported by others tudies [9, 12, 13, 45] .
Discussion
We reportt hat Aicda-deficientm ice are protected against rhMOG-induced EAE in am anners imilar to Bc ell-deficient (uMT) mice, supporting the hypothesis that high affinity isotype switched Bc ells and/or antibodies play acritical role in the EAE pathogenesis. uMT miceh aveablock in early Bc ell development and lack mature Bcells due to atargeted disruptionof the transmembraneIgM heavy chain [46] . In contrast, naïveBcellsa re present in the Aicda-deficient mice; AID-deficient Bc ells are only defective in SHM and CSR [20] . Given the SHM/CSR specific defects in the Aicda -deficient mice, our results have broad implications for the role of Bc ells in autoimmunity andt herapeutic interventions aimeda td ifferent subsetsofBc ells.
Antigens pecific matureBcells arei mportant modulatorsofthe immuneresponse. First, Bcells are highlys ensitive APC compared to other professional APCs due to selective recognition of antigen through the Bcell receptor and may be the first APCs to capture and present self-antigens to Tc ells [3] .S econd, activated Bcells also produce cytokines andmembrane associated molecules that provide cognate help to modulatet he inflammatoryr esponse [4, 5] . Finally, secreteda uto-antibodies maym ediate tissued amage [6 -13] .High affinity Bcell receptor or auto-antibodies that are isotypes witched may impact all aspectso f Bc ell functions outlined above; however, our data is consistent with the hypothesis that the resistance in Aicda-deficientanimals maybemediatedprimarily by the lack of high affinity pathogenic auto-antibodies. Our in vitro Tc ell functional studies suggest that the protection observed in Aicda-deficient animals is not due to ad efect in Tc ell activation or effector function. Thus there is not adefect in Tcell primingin the Aicda deficient animals.Inthis context,the BCRmediated antigen recognition or processing does not appear to profoundly affect Tc ell function however furthers tudies in different anatomical locations are needed to rule this possibility out. Forexample, access of neoantigen is limitedi nt he CNS and autoantibodiescould facilitate Bcell APC function in CNSvia opsonization of the neoantigens [47] .
The pathogenic roleo fa utoantibodies in rhMOG inducedE AE hasb een established [9, 12, 13, 45] . These auto-antibodies may enhance demyelination [6 -9,12,13,45] , affect trafficking of encephalitogenic Tc ells intot he CNS [45, 47] or impacti mmune regulation [4, 48] . Although IgM anti-MOG antibodies ared etected in WT and Aicda KO mice, these antibodies in both groups do not appear to be of high affinityb asedo no ur MOG antigen binding studies andimmunofluorescenceonbrain tissue. Our competition binding measurements show that amajor portion of the high affinitya nti-MOG antibodies is IgG1 that are completelyabsent in the Aicda KO mice.
TheW TI gG1a ntibodies areg eneratedf rom antigen experienced activated Bc ells and therefore usually selected as high affinitya ntibodies. Accordingly,weshow that white matter binding IgG1 can be demonstrated by indirect fluorescence in the serumof EAE affected WT animals, whereas sucha ntibodies are not present in normal mouse serum or serum of MOG immunized Aicda KO mice. This is consistent with rhMOG induced EAE where autoantibodies can exacerbate disease [9, 45] .
An interesting observation from this study is that IgM anti-MOG antibodiesare even more abundantin Aicda KO mice than WT.T he exactr oleo ft he unmutated pool of antibodiesi su nclear, but others havep roposed that unmutated germ-linee ncoded IgM antibodies might play aprotective role by clearing apoptotic cells and/or antigens from injurys ites to minimize inflammation or autoimmunity [49] [50] [51] [52] [53] [54] [55] . It is important to note that in addition to its use in immuned eficiencies, intravenousi mmunoglobulin therapy is used in the treatment of several inflammatoryc onditions, including Kawasaki disease, dermatomyositis and antineutrophil cytoplasmic antibody (ANCA)-positive vasculitis [56] .
In experimental models, the therapeutic benefit of pooled intravenous IgMf or immune-mediated inflammatoryd iseases such as experimental autoimmune uveitis,e xperimentalm ultiple sclerosis and experimental myas thenia gravis hasb een established [ 55] . In addition, transgenic mice engineered to produce high titersofauto-antibodies against MOG havea ne xacerbated formo fE AE [45, 57] and MS patients have ah igher prevalence of IgG switched, but not IgM isotype, anti-MOG antibodies than healthy controls [17] . Additional studies are needed to address howp reciselyBcell function is altered in Aicda KO mice in the context of the autoimmunity experimental models.
The contribution of Bcells in EAE model has been controversial and partofthis is due to the nature of the antigen that is used to invoke thea utoimmune response. Properly folded recombinanthumanMOG assumesathreed imensional conformationa nd contains diverse epitopes that may facilitate Bc ell specific activation [58] . In contrast, MOG peptide 35 -55m imics al inear epitope that can directly bind to MHCc lass II on any APCt oi nduce EAE [59] . Correspondingly,Bcells do not appear to play amajor role in induction or maintenance of MOG peptide 35 -55i nduced EAE, as both Bc ell deficient (uMT) [60] and Aicda-deficient mice were equally susceptible in this model [61] . Therefore the selection of the appropriate EAE model is important when interrogating the contribution of variouscell types such as Bor Tl ymphocytes.
Although considerable work needs to be performed to better understand the mechanismsbywhich Bcells influence autoimmune diseases, clinicald atai s suggesting an important role for Bc ellsi nh uman patients( reviewed in [2, 62] ).T he elucidationo fh ow AID dependentp rocesses contribute to MS pathogenesis ultimately will help with the design of better treatments for MS and otherinflammatorydiseases by investingo nd ruggable pathways or molecules that modulater elevant Bc ell functions.
